One of its lead clinical investigators, Kanti R. Rai, MD, has dedicated nearly 40 years to diagnosing and treating CLL. He led the landmark research that created the Rai staging system for determining patient prognosis.
The Karches family’s support helped fuel Dr. Rai’s collaboration with Nicholas Chiorazzi, MD, and other CLL scientists at the Feinstein Institute. Their findings into how CLL develops and evolves have played a pivotal role in refining patient prognosis and in developing second-line treatments, which are employed when the disease doesn’t respond to typical interventions.
Susan Karches also has emerged as an advocate for the revolutionary field of bioelectronic medicine. As a member of the Feinstein Institute’s board of directors, Susan had an early opportunity to learn from Dr. Kevin Tracey about how we can harness the nervous system to detect and treat disease and injuries. As a result, she established the Karches Neural Bypass and Brain-Computer Interface Laboratory as part of the Feinstein Institute’s Center for Bioelectronic Medicine.
Susan’s generosity allowed Professor Chad Bouton, who leads the Karches Lab, to establish a program focused on paralysis and brain injury that will pave the way to new treatment options for patients.
Thanks to Susan’s more than three decades of philanthropic support and involvement with the Feinstein Institute, the Karches name will forever be linked to discoveries in medicine that hold the possibility of impacting countless lives.